Life sciences innovation is moving fast these days, and perhaps nowhere is this more evident than in Boston. Local companies, researchers, and entrepreneurs are pursuing some of the boldest ideas in the field—T-cell therapy, gene therapy, and microbiome analysis, among others. What's more, they're seeing real results, in human trials, that indicate these approaches might soon change the way a number of diseases are treated. But a whole host of hurdles still have to be cleared. How can we avoid the pitfalls of the past, and turn these innovative visions into a reality? What’s it going to take to get new types of treatments approved? And how will we pay for them?
Join Xconomy as we bring together a group of Boston biotech’s top innovators, entrepreneurs, investors, and leaders as we explore the brightest spots on the life sciences horizon.
David Altshuler, Executive VP of Global Research and CSO, Vertex Pharmaceuticals
Susan Lindquist, Member, Whitehead Institute; Scientific Founder, Yumanity Therapeutics
Noubar Afeyan, Managing Partner and CEO, Flagship Ventures; Visiting Scholar, Wyss Institute
Alexis Borisy, Chairman, Foundation Medicine; Partner, Third Rock Ventures
Tony Coles, CEO, Chairman, and Founding Investor, Yumanity Therapeutics
James Collins, Professor of Medical Engineering & Science, MIT; Core Faculty Member, Wyss Institute, Harvard University
Olivier Danos, Senior Vice President, Gene Therapy, Biogen
Michelle Dipp, Co-founder and CEO, OvaScience
Peter Kolchinsky, Managing Member and Portfolio Manager, RA Capital Management
Adam Koppel, Senior Vice President and Chief Strategy Officer, Biogen
Marian Nakada, Vice President of Venture Investments, Johnson & Johnson Innovation
Amir Nashat, Managing Partner, Polaris Partners
Bernat Olle, Principal, PureTech Ventures
Steve Paul, President and CEO, Voyager Therapeutics
Samantha Singer, COO, The Broad Institute of MIT and Harvard
Ben Auspitz, Partner, Fidelity Biosciences
Chuck Wilson, CEO and President, Unum Therapeutics
View our full agenda here
Registration & Networking: 12:30 - 1:30 pm
Program: 1:30 - 5:30 pm
Networking Reception: 5:30 - 6:30 pm
Tickets are transferable but not refundable.
To inquire about press registration, email firstname.lastname@example.org.
*Speakers and program schedule are subject to change.
VENTURE CAPITAL MEMBERS
LIFE SCIENCE MEMBERS
When & Where
Xconomy is an innovative news and events organization with outposts in Boston, Boulder/Denver, Detroit/Ann Arbor, Indiana, New York, Raleigh-Durham, San Diego, San Francisco, Seattle, Texas, and Wisconsin. It is dedicated to providing business and technology leaders with timely, insightful, close-to-the-scene information about the local personalities, companies, and technological trends that best exemplify today’s high-tech economy. Xconomy is staffed by world-class journalists and media professionals, and supported by “the Xconomists,” who include some of the world’s leading innovators. Get to know them and the Xconomy team at www.xconomy.com/about.
Sign up for RSS feeds, daily email newsletters, and email alerts from Xconomy at http://www.xconomy.com/rss-feeds/.